Sleep dysfunction in Parkinson's disease

Clinical Neuroscience

Volumn 5, Issue 2, 1998, Pages 107-114

  Trenkwalder, Claudia ^a,b  

^a UNIVERSITY OF MUNICH   (Germany)

^b MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Depression; Dopamine; Hallucination; Parkinson's disease; REM sleep behavior disorder; Sleep; Tremor

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOZAPINE; DOPAMINE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA;

AROUSAL; BLINKING; DEPRESSION; DYSKINESIA; HALLUCINATION; HUMAN; IMMOBILIZATION; LIMB MOVEMENT; MYOCLONUS; NIGHTMARE; PARKINSON DISEASE; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PSYCHOSIS; REM SLEEP; RESPIRATORY FAILURE; RESTLESS LEGS SYNDROME; REVIEW; SLEEP DISORDER; TREMOR; VIOLENCE;

DEPRESSION; EXTREMITIES; HUMAN; MOVEMENT; MOVEMENT DISORDERS; PARKINSON DISEASE; PSYCHOTIC DISORDERS; RESPIRATION DISORDERS; SLEEP; SLEEP DISORDERS;

EID: 0032471174     PISSN: 10656766     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (89)

1. Aldrich M (1994): Parkinsonism. In: Kryger M, Roth T, Dement W, editors. Principles and practice of sleep medicine. Philadelphia: W.B. Saunders. p 783-789.
2. Ancoli-Israel S, Kripke DF, Klauber MR, Mason WJ, Fell R, Kaplan O (1991): Periodic limb movements in sleep in community-dwelling elderly. Sleep 14:496-500.
3. Apps MCP, Sheaff PC, Ingram DA, Kennard C, Empey DW (1985): Respiration and sleep in Parkinson's disease. J Neurol Neurosurg Psychiatry 48:1240-1245.
4. April RS (1966): Observations on parkinsonian tremor in all-night sleep. Neurology 16:720-724.
5. ASDA (American Sleep Disorders Association) (1990): Periodic limb movements disorder and restless legs syndrome. The international classification of sleep disorders diagnostic and coding manual. Lawrence, KS: Allen Press, p 65-71.
6. Askenasy JJ (1993): Sleep in Parkinson's disease. Acta Neurol Scand 87:167-170.
7. Askenasy JJM, Yahr MD (1985): Reversal of sleep disturbance in Parkinson's disease by antiparkinsonian therapy: a preliminary study. Neurology 35:527-532.
8. Askenasy JJM, Yahr MD (1990): Parkinsonian tremor loses its alternating aspect during non-REM sleep and is inhibited by REM sleep. J Neurol Neurosurg Psychiatry 53:749-753.
9. ATF (Atlas Task Force of the American Sleep Disorders Association) (1993): Recording and scoring leg movements. Sleep 16:748-759.
10. Bliwise D, Petta D, Seidel W, Dement W (1985): Periodic leg movements during sleep in the elderly. Arch Gerontol Geriatr 4:273-281.
11. Brodeur C, Montplaisir J, Godbout R, Marinier R (1988): Treatment of restless legs syndrome and periodic movements during sleep with L-dopa: a double-blind, controlled study. Neurology 38: 1845-1848.
12. Broughton R, Tolentino M, Krelina M (1985): Excessive fragmentary myoclonus in NREM sleep: a report of 38 cases. Electroencephalogr Clin Neurophysiol 61:123-309.
13. Chaudhuri KR, Gathani T, Agapito C, Clough C (1999): Comparative study of the effect of pergolide and cabergoline on nocturnal disabilities in Parkinson's disease: a single blind study. Neurology (in press).
14. Chokroverty S (1990): The spectrum of ventilatory disturbances in movement disorders. In: Chokroverty S, editor. Movement disorders. Costa Mesa, CA: PMA. p 365.
15. Chokroverty S (1994): Sleep, breathing and neurological disorders. In: Chokroverty S, editor. Sleep disorders medicine: basic science, technical considerations and clinical aspects. Boston: Butterworth-Heinemann. p 295-297.
16. Chokroverty S (1996): Sleep and degenerative neurologic disorders. Neurol Clin 14:807-826.
17. Chokroverty S, Sachdeo R, Masdeu J (1984): Autonomic dysfunction and sleep apnea in olivopontocerebellar degeneration. Arch Neurol 41:926-931.
18. Cianchetti C, Masala C, Mangoni A, Gessa GL (1980): Suppression of REM and delta sleep by apomorphine in man: a dopamine mimetic effect. Psychopharmacology 67:61-56.
19. Comella CL, Tanner CM, Ristanovic RK (1993): Polysomnographic sleep measures in Parkinson's disease patients with treatment induced hallucinations. Ann Neurol 34:710-714.
20. Comella C, Nardine T, Diederich N, Stebbins G (1998): Sleep-related violence, injury, and REM sleep behavior disorder in Parkinson's disease. Neurology 51: 526-529.
21. Critchley PHS, Malcolm GP, Malcolm PN, Gibb WR, Arend R, Parkes JD (1991): Fatigue and melatonin in Parkinson's disease. J Neurol Neurosurg Psychiatry 54:91-92.
22. Culebras A (1992): Neuroanaromic and neurologic correlates of sleep disturbances. Neurology 42:19-27.
23. Culebras A, Moore JT (1989): Magnetic resonance findings in REM sleep behavior disorder. Neurology 39:1519-1523.
24. Culpepper W, Badia P, Shaffer J (1992): Time-of-night patterns in PLMS activity. Sleep 15:306-311.
25. Currie LJ, Bennett JP, Harrison MB, Trugman JM, Wooten GF (1997): Clinical correlates of sleep benefit in Parkinson's disease. Neurology 48:1115-1117.
26. Efthimiou J, Ellis SJ, Hardie RJ, et al (1986): Sleep apnea in idiopathic and postencephalitic parkinsonism. In: Yahr MD, Bergmann KJ, editors. Parkinson's disease. New York: Raven Press, p 275.
27. Eisensehr I, Linke R, Tatsch K, Noachtar S (1999): Reduced striatal dopamine transporters in idiopathic REM sleep behavior disorder. APSS-Meeting, Orlando (Abstract).
28. Factor S, McAlarney T, Sanchez-Ramos J, Weiner W (1990): Sleep disorders and sleep effect in Parkinson's disease. Mov Disord 5:280-285.
29. Fischer P, Naske R (1992): Akathisia-like motor restlessness in major depression responding to serotonin-reuptake inhibition. J Clin Psychopharmacol 12:295-296.
30. Fish D, Sawyers D, Allen PJ, Blackie JD, Lees AJ, Marsden D (1991): The effect of sleep on the dyskinetic movements of Parkinson's disease, Gille de la Tourette's syndrome, Huntington's disease, and torsion dystonia. Arch Neurol 48:210-214.
31. Friedmann A (1980): Sleep pattern in Parkinson's disease. Acta Med Pol 21:193-199.
32. Gillin J, Post R, Wyatt R, Goodwin F, Snyder F, Bunney W (1973): REM inhibitory effect of L-dopa infusion during human sleep. Electroenceph Clin Neurophysiol 35:181-186.
33. Goetz CG, Lutge W, Tanner CM (1986a): Autonomic dysfunctions in Parkinson's disease. Neurology 36:73-75.
34. Goetz CG, Wilson RS, Tanner CM, Garron DC (1986b): Relationships among pain, depression, and sleep alterations in Parkinson's disease. Adv Neurol 45:345-347.
35. Gotham AM, Brown RG, Marsden CD (1986): Depression in Parkinson's disease: a quantitative and qualitative analysis. J Neurol Neurosurg Psychiatry 49:381-389.
36. Guilleminault C, Briskin JG, Greenfield MS, Silvestri R (1981): The impact of autonomic nervous system dysfunction on breathing during sleep. Sleep 4:263-268.
37. Hegeman RJ, Schiffer RB, Kurlan R (1996): Anxiety and Parkinson's disease. J Neuropsychiatry Clin Neurosci 8:383-392.
38. Hillen ME, Sage JI (1996): Nonmotor fluctuations in patients with Parkinson's disease. Neurology 47:1180-1183.
39. Högl BE, Gömez-Arévalo G, García S, Scipioni O, Rubio M, Blanco M, Gershanik OS (1998): A clinical, pharmacologic, and polysomnographic study of sleep benefit in Parkinson's disease. Neurology 50:1332-1339.
40. Högl B, Rothdach A, Wetter TC, Trenkwalder C (1999): Effects of cabergoline on sleep and morning motor performance in patients with Parkinson's disease. Eur J Neurol 6:525-528.
41. Horvath TB, Meares RA (1974): L-dopa and arousal. J Neurol Neurosurg Psychiatry 37:416-421.
42. Hovestadt A, Bogaard JM, Meerwaldt JD, van der Meche FG, Stigt J (1989): Pulmonary function in Parkinson's disease. J Neurol Neurosurg Psychiatry 52:329-333.
43. Jansen ENH, Meerwaldt JD (1990): Madopar HBS in nocturnal symptoms of Parkinson's disease. In: Streifler MB, Korczyn AD, Melamed E, Youdim MBH, editors. Advances in neurology: Parkinson's disease: anatomy, pathology, and therapy. New York: Raven Press, p 527-531.
44. Jellinger KA (1991): Pathology of Parkinson's disease. Changes other than the nigrostriatal pathway. Mol Chem Neuropathol 14:153-197.
45. Klawans H, Goetz C, Bergen D (1975): L-dopa-induced myoclonus. Arch Neurol 32:331-334.
46. Kostic VS, Susic V, Przedborski S, Sternic N (1991): Sleep EEG in depressed and nondepressed patients with Parkinson's disease. J Neuropsychiatry Clin Neurosci 3:176-179.
47. Lang A, Johnson K (1987): Akathisia in idiopathic Parkinson's disease. Neurology 37:477-481.
48. Lapierre O, Montplaisir J (1992): Polysomnographic features of REM sleep behavior disorder: development of a scoring method. Neurology 42:1371-1374.
49. Lauterbach EC, Duvoisin RC (1992): Anxiety disorders in familial parkinsonism (letter). Am J Psychiatry 148:274.
50. Leeman AL, O'Neill CJA, Nicholson PW, Deshmukh AA, Denham MJ, Royston JP, Dobbs RJ, Dobbs SM (1987): Parkinson's disease in the elderly: response to and optimal spacing of night time dosing with levodopa. Br J Clin Pharmac 24:637-643.
51. Lees AJ (1987): A sustained release formulation of L-dopa (Madopar HBS) in the treatment of nocturnal and early morning disabilities in Parkinson's disease. Eur Neurol 27:126.
52. Lees A, Blackburn N, Campbell V (1988): The nighttime problems in Parkinson's disease. Clin Neuropharmacol 11:512-519.
53. Lesser RP, Fahn S, Snider SR, Cote LJ, Isgreen WP, Barrett RE (1979): Analysis of the clinical problems in parkinsonism and the complications of long-term levodopa therapy. Neurology 29:1253-1260.
54. Linazasoro G, Masso JM, Suarez J (1993): Nocturnal akathisia in Parkinson's disease: treatment with clozapine. Mov Disord 8:171-174.
55. Louis E, Marder K, Cote L, Tang M, Mayeux R (1997): Mortality from Parkinson's disease. Arch Neurol 54:260-264.
56. Lugaresi E, Cirignotta F, Coccagna G, Montagna P (1986): Nocturnal myoclonus and restless legs syndrome. Adv Neurol 43:295-307.
57. Mahowald M, Schenck C (1994): REM sleep behavior disorder. In: Kryger M, Roth T, Dement W, editors. Principles and practice of sleep medicine. Philadelphia: WB Saunders. p 574-588.
58. Menza MA, Rosen RC (1995): Sleep in Parkinson's disease. Psychosomatics 36:262-266.
59. Merello M, Hughes A, Colosimo C, Hoffman M, Starkstein S, Leiguarda R (1997): Sleep benefit in Parkinson's disease. Mov Disord 12:506-508.
60. Mouret J (1975): Differences in sleep in patients with Parkinson's disease. Electroencephalogr Clin Neurophysiol 38:653-657.
61. Nausieda P (1990): Sleep in Parkinson's disease. In: Thorpy M, editor. Handbook of sleep disorders. New York: Marcel Dekker. p 719-733.
62. Nausieda PA, Weiner WJ, Kaplan LR, Weber S, Klawans HL (1982): Sleep disruption in the course of chronic levodopa therapy: an early feature of the levodopa psychosis. Clin Neuropharmacol 5:183-194.
63. Pappert EJ, Goetz CG, Niederman FG, Raman R, Leurgans S (1999): Hallucinations, sleep fragmentation, and altered dream phenomena in Parkinson's disease. Mov Disord 14:117-121.
64. Plazzi G, Corsini R, Provini F, Pierangeli G, Martinelli P, Montagna P, Lugaresi E, Cortelli P (1997): REM sleep behavior disorders in multiple system atrophy. Neurology 48:1094-1097.
65. Puca F, Bricolo A, Rurella G (1973): Effect of L-dopa or amantadine therapy on sleep spindles in parkinsonism. Electroencephalogr Clin Neurophysiol 35:327-330.
66. Reynolds CF, Kupfer DJ (1987): Sleep research in affective illness: state of the art circa 1987. Sleep 10:199-215.
67. Riley DE, Lang AE (1993) The spectrum of levodopa-related fluctuations in Parkinson's disease. Neurology 43:1459-1464.
68. Rye DB, Bliwise DL (1997): Movement disorders specific to sleep and the nocturnal manifestations of waking movement disorders. In: Watts RL, Koller WC, editors. Neurologic principles and practice. New York: McGraw-Hill. p 687-713.
69. Sage JI, Mark MH (1991): Nighttime levodopa infusions to treat motor fluctuations in advanced Parkinson's disease: preliminary observations. Ann Neurol 30:616-617.
70. Schenck CH, Mahowald MW (1993): Five cases of parkinsonism emerging after the onset of REM sleep behavior disorder (RBD) in men aged 58-79 years. Sleep Res 22:261.
71. Schenck CS, Bundlie SR, Ettinger MG, Mahowald MW (1986): Chronic behavioral disorders of human REM sleep: a new category of parasomnia. Sleep 9:293-308.
72. Starkstein SE, Preziosi TJ, Robinson RG (1991): Sleep disorders, pain, and depression in Parkinson's disease. Eur Neurol 31:352-355.
73. Stern M, Roffwarg H, Duvoisin R (1968): The parkinsonian tremor in sleep. J Nerv Ment Dis 147:202-210.
74. Tandberg E, Larsen J, Karlsen K (1998): A community-based study of sleep disorders in patients with Parkinson's disease. Mov Disord 13:895-899.
75. Tassinari CA, Broughten R, Poire R (1965): An electro-clinical study of nocturnal sleep in patients presenting abnormal movements. Electroencephalogr Clin Neurophysiol 18:95.
76. Taylor AE, Saint-Cyr JA (1990): Depression in Parkinson's disease: reconciling physiological and psychological perspectives. J Neuropsychiatry Clin Neurosci 2:92-98.
77. Trenkwalder C, Wagner M, Gasser T, Poewe W, Oertel WH (1991): Long-term treatment with slow-release levodopa (Madopar HBS) in parkinsonian patients with nocturnal disabilities. In: Agnoli A, Campanella G, editors. New developments in therapy of Parkinson's disease. Rome: John Libbey. p 23-27.
78. Trenkwalder C, Stiasny K, Pollmaecher T, Wetter T, Schwarz J, Kohnen R, Krueger HP, Kazenwadel J, Ramm S, Kuenzel M, Oertel WH (1995): L-DOPA therapy of uremic and idiopathic restless legs syndrome: a double-blind crossover trial. Sleep 18:681-688.
79. Trenkwalder C, Hening WA, Walters AS (1996): Periodic limb movements and restless legs syndrome. Neurol Clin 14: 629-650.
80. Trenkwalder C, Wetter TC, Tagaya H, Collado-Seidel V, Friess E (1998b): Sleep disorders in Parkinson syndromes: the role of the dopaminergic system on motor disturbances and REM-sleep. Electroenceph Clin Neurophysiol 107:50.
81. Uchiyama M, Isse K, Tanaka K, Yokota N, Hamamoto M, Aida S, Ito Y, Yoshimura M, Okawa M (1995): Incidental Lewy body disease in a patients with REM sleep behavior disorder. Neurology 45: 709-712.
82. van Hilten JJ, Weggeman M, van der Velde EA, Kerkhof GA, van Dijik JG, Roos RA (1993): Sleep, excessive daytime sleepiness and fatigue in Parkinson's disease. J Neurol Transm 5:235-244.
83. van Hilten B, Hoff JI, Middelkoop HAM, van der Velde EA, Kerkhof GA, Wauquier A, Kamphuisen HAC, Roos RA (1994): Sleep disruption in Parkinson's disease. Arch Neurol 51:922-928.
84. Walters AS, Hening WA, Kavey N, Chokroverty S, Gidro-Frank S (1988): A double-blind randomized crossover trial of bromocriptine and placebo in restless legs syndrome. Ann Neurol 24:455-458.
85. Walters AS, Wagner ML, Hening WA, Grasing K, Mills R, Chokroverty S, Kavey N (1993): Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 16:327-332.
86. Walters AS, The International Restless Legs Syndrome Study Group (1995): Towards a better definition of the restless legs syndrome. Mov Disord 10:634-642.
87. Wetter TC, Stiasny K, Winkelmann J, Buhlinger A, Brandenburg U, Penzel T, Medori R, Rubin M, Oertel WH, Trenkwalder C (1999): A randomized controlled study of pergolide in patients with restless legs syndrome. Neurology 52:944-950.
88. Wetter TC, Collado-Seidel V, Pollmacher T, Yassouridis A, Trenkwalder C (2000): Sleep and periodic leg movement patterns in drug-free patients with Parkinson's disease and multiple system atrophy. Sleep (in press).
89. Zweig RM, Jankel WR, Hedreen JC, Mayeux R, Price DL (1989): The pedunculopontine nucleus in Parkinson's disease. Ann Neurol 26:41-46.